journal
https://read.qxmd.com/read/35469191/cystatin-c-based-equations-detect-hidden-kidney-disease-and-poor-prognosis-in-newly-diagnosed-patients-with-multiple-myeloma
#21
JOURNAL ARTICLE
Francisco-Javier Cepeda-Piorno, Esther González-García, Alba Méndez-Gallego, Juan Torres-Varona, Vanesa García-Moreira, Christian Sordo-Bahamonde, Cristina AlberdiGarcía-Del-Castillo, Elene Astobieta-Madariaga, Maria-Victoria Mateos-Manteca, Segundo González-Rodríguez
OBJECTIVES: The aim of this study was to compare the creatinine equations with cystatin C (CysC) equations to define renal impairment (RI) in newly diagnosed multiple myeloma (MM) patients and to analyse the equation that allows for identifying patients with more and worse prognostic factors. METHODS: Renal function was evaluated prospectively in 61 patients with newly diagnosed untreated MM employing CKD-EPI and CAPA equations. The comparison was conducted using Bland-Altman graphics and Cohen's Kappa statistic...
2022: Advances in Hematology
https://read.qxmd.com/read/35378848/concordance-of-peripheral-blood-and-bone-marrow-next-generation-sequencing-in-hematologic-neoplasms
#22
JOURNAL ARTICLE
Chayanit Jumniensuk, Alexander Nobori, Thomas Lee, T Niroshi Senaratne, Dinesh Rao, Sheeja Pullarkat
OBJECTIVE: Mutational analysis by next-generation sequencing (NGS) obtained by peripheral blood NGS has been of clinical interest to use as a minimally invasive screening tool. Our study evaluates the correlation between NGS results on peripheral blood and bone marrow in hematolymphoid disease. METHOD: We evaluated patients who had NGS for presumed hematologic malignancy performed on peripheral blood and bone marrow within a 1-year interval of each other. We excluded cases in which chemotherapy or bone marrow transplant occurred in the interval between the two tests...
2022: Advances in Hematology
https://read.qxmd.com/read/35189630/bone-marrow-infiltration-is-a-distinctive-risk-factor-for-rituximab-infusion-related-reactions-in-cd20-positive-b-cell-non-hodgkin-lymphoma
#23
JOURNAL ARTICLE
Shinya Ohata, Kei Takenaka, Daisuke Sugiyama, Takeshi Sugimoto
BACKGROUND: Bone marrow infiltration of lymphoma cells is a candidate risk factor for infusion-related reactions (IRRs) in patients with CD20-positive B-cell non-Hodgkin lymphoma (B-NHL). However, despite with the lack of sufficient data, the effect of bone marrow infiltration of B-NHL cells on the incidence rate of grade 2 or higher IRRs with the administration of rituximab has been retrospectively studied in this paper. METHODS: Patients with CD20-positive B-NHL who received the rituximab induction therapy for the first time were enrolled in this study...
2022: Advances in Hematology
https://read.qxmd.com/read/35126524/safety-and-efficacy-of-subcutaneous-rituximab-in-previously-untreated-patients-with-cd20-diffuse-large-b-cell-lymphoma-or-follicular-lymphoma-results-from-an-italian-phase-iiib-study
#24
JOURNAL ARTICLE
Mario Petrini, Gianluca Gaidano, Andrea Mengarelli, Ugo Consoli, Armando Santoro, Anna Maria Liberati, Marco Ladetto, Vincenzo Fraticelli, Attilio Guarini, Donato Mannina, Paola Ferrando, Paolo Corradini, Pellegrino Musto, Caterina Stelitano, Dario Marino, Andrea Camera, Marco Murineddu, Roberta Battistini, Giuseppe Caparrotti, Mauro Turrini, Luca Arcaini, Simone Santini, Manuela Cerqueti, Andres J M Ferreri, Nicola Cantore, Alessandro Inzoli, Giovanni Cardinale, Benedetto Ronci, Giorgio La Nasa, Stefano Massimi, Gianfranco Gaglione, Valentina Barbiero, Maurizio Martelli
Subcutaneous (SC) rituximab may be beneficial in terms of convenience and tolerability, with potentially fewer and less severe administration-related reactions (ARRs) compared to the intravenous (IV) form. This report presents the results of a phase IIIb study conducted in Italy. The study included adult patients with CD20+ DLBCL or FL having received at least one full dose of IV RTX 375 mg/m2 during induction or maintenance. Patients on induction received ≥4 cycles of RTX SC 1400 mg plus standard chemotherapy and FL patients on maintenance received ≥6 cycles of RTX SC...
2022: Advances in Hematology
https://read.qxmd.com/read/35103064/ibrutinib-plus-obinutuzumab-as-frontline-therapy-for-chronic-lymphocytic-leukemia-is-associated-with-a-lower-rate-of-infusion-related-reactions-and-with-sustained-remissions-after-ibrutinib-discontinuation-a-single-arm-open-label-phase-1b-2-clinical-trial-nct0231576
#25
JOURNAL ARTICLE
Januario E Castro, Paula A Lengerke-Diaz, Juliana Velez Lujan, Michael Y Choi, Eider F Moreno-Cortes, Jose V Forero, Juan Esteban Garcia-Robledo, Chaja Jacobs, Colin McCarthy, Alaina Heinen, Carlos I Amaya-Chanaga, Thomas J Kipps
Ibrutinib-based therapies are costly and require continuous administration. We hypothesized combining BTK inhibition with anti-CD20 monoclonal antibodies would yield deep remissions allowing discontinuation. We enrolled 32 therapy-naïve CLL patients to receive ibrutinib plus obinutuzumab, followed by single-agent ibrutinib. Patients could discontinue ibrutinib after 36 months with sustained complete response (CR). We evaluated treatment safety, efficacy, and outcomes after ibrutinib discontinuation. The overall response rate was 100%, 28% achieved a CR, and 12...
2022: Advances in Hematology
https://read.qxmd.com/read/35103063/anaemia-prevalence-more-than-doubles-in-an-academic-year-in-a-cohort-of-tertiary-students-a-repeated-measure-study-in-cape-coast-ghana
#26
JOURNAL ARTICLE
Regina Elorm Amoaning, Ernestina Siaw Amoako, Grace Arezie Kyiire, Dennis Dela Owusu, Happy Bruce, David Larbi Simpong, Patrick Adu
BACKGROUND: The stress of academic life may predispose young adults to poor dietary habits, which could potentially precipitate nutritional deficiencies, such as iron deficiency. This study evaluated factors predictive of optimal iron stores as well as changes in haematological parameters over the course of an academic year in a cohort of tertiary students. MATERIALS AND METHODS: The repeated-measure cohort study recruited 117 undergraduate students from September 2018 to May 2019...
2022: Advances in Hematology
https://read.qxmd.com/read/35096069/utility-of-bruton-s-tyrosine-kinase-inhibitors-in-light-chain-amyloidosis-caused-by-lymphoplasmacytic-lymphoma-waldenstr%C3%A3-m-s-macroglobulinemia
#27
JOURNAL ARTICLE
Maroun Bou Zerdan, Jason Valent, Maria Julia Diacovo, Karl Theil, Chakra P Chaulagain
Of the variety of immunoglobulin related amyloidosis (AL), immunoglobulin M (IgM) related AL represents only 6 to 10% of affected patients, and the majority of these cases are associated with underlying non-Hodgkin's Lymphoma including Waldenström's macroglobulinemia (WM). Ibrutinib, acalabrutinib, and zanubrutinib are Bruton tyrosine kinase (BTK) inhibitors approved for certain indolent B cell non-Hodgkin's lymphoma (NHL). BTK is a nonreceptor kinase involved in B-cell survival, proliferation, and interaction with the microenvironment...
2022: Advances in Hematology
https://read.qxmd.com/read/34970315/evaluation-of-anticoagulation-control-among-patients-taking-warfarin-in-university-of-gondar-hospital-northwest-ethiopia
#28
JOURNAL ARTICLE
Zelalem Liyew, Abilo Tadesse, Nebiyu Bekele, Tewodros Tsegaye
INTRODUCTION: Warfarin is a widely used oral anticoagulant in clinical practice. It has variable intraindividual and interindividual dose response and a narrow therapeutic index. Therefore, it requires frequent and regular international normalized ratio (INR) determination to maintain the INR within the therapeutic range. The study evaluated parameters of anticoagulation control among patients on warfarin. METHODS: A cross-sectional study was conducted at University of Gondar hospital...
2021: Advances in Hematology
https://read.qxmd.com/read/34733330/heritable-thrombophilia-in-venous-thromboembolism-in-northern-pakistan-a-cross-sectional-study
#29
JOURNAL ARTICLE
Maria Khan, Chaudhry Altaf, Hamid Saeed Malik, Muhammad Abdul Naeem, Aamna Latif
BACKGROUND: Venous thromboembolism (VTE) is referred to as formation of clots in a deep vein or lodging of thrombus towards the lungs which could be fatal yet preventable. The risk of developing VTE can be increased by various factors. Where there are innumerable acquired causes, the possibility of inherited thrombophilia cannot be ignored. In view of this, we have evaluated all patients with venous thromboembolism for inherited thrombophilia. OBJECTIVE: To evaluate the frequencies of antithrombin (AT) deficiency, protein C and S deficiencies, Factor V Leiden, and prothrombin gene mutations in patients harboring venous thromboembolism...
2021: Advances in Hematology
https://read.qxmd.com/read/34721583/haptoglobin-gene-polymorphism-among-sickle-cell-patients-in-west-cameroon-hematological-and-clinical-implications
#30
JOURNAL ARTICLE
Christian Bernard Kengne Fotsing, Constant Anatole Pieme, Prosper Cabral Biapa Nya, Jean Paul Chedjou, Samuel Ashusong, Gisele Njindam, Jocelyn Tony Nengom, Georges Teto, Carine Nguemeni, Wilfred Fon Mbacham, Donatien Gatsing
Haptoglobin is a protein involved in protecting the body from the harmful effects of free hemoglobin. The haptoglobin gene exhibits a polymorphism, and the different genotypes do not have the same capacity to combat the free hemoglobin effects. The present study aimed at determining the polymorphic distribution of haptoglobin in sickle cell patients (SCPs) from West Cameroon and their impact on the hematological parameters, as well as clinical manifestations of the disease severity. Haptoglobin genotype of 102 SCPs (SS) and 115 healthy individuals (60 AA and 55 AS) was determined by allele-specific polymerase chain reaction, and the complete blood count was determined using the AutoAnalyser...
2021: Advances in Hematology
https://read.qxmd.com/read/34335777/il-31-and-il-8-in-cutaneous-t-cell-lymphoma-looking-for-their-role-in-itch
#31
JOURNAL ARTICLE
Maria Abreu, Marta Miranda, Mafalda Castro, Iolanda Fernandes, Renata Cabral, Ana Helena Santos, Sónia Fonseca, João Rodrigues, Magdalena Leander, Catarina Lau, Inês Freitas, Susana Coimbra, Alice Santos-Silva, Margarida Lima
The itch associated with cutaneous T-cell lymphoma (CTCL), including Mycosis Fungoides (MF) and Sézary syndrome (SS), is often severe and poorly responsive to treatment with antihistamines. Recent studies have highlighted the possible role of interleukins in nonhistaminergic itch. We investigated the role of IL-31 and IL-8 in CTCL, concerning disease severity and associated itch. Serum samples of 27 patients with CTCL (17 MF and 10 SS) and 29 controls (blood donors) were analyzed for interleukin- (IL-) 31 and IL-8; correlations with disease and itch severity were evaluated...
2021: Advances in Hematology
https://read.qxmd.com/read/33859695/a-phase-ii-trial-of-melphalan-based-reduced-intensity-conditioning-for-transplantation-of-t-replete-hla-haploidentical-peripheral-blood-stem-cells-with-posttransplant-cyclophosphamide-in-patients-with-hematologic-malignancies
#32
JOURNAL ARTICLE
Melhem M Solh, Gabriel Hinojosa, Justin Laporte, Scott R Solomon, Lawrence E Morris, Xu Zhang, H Kent Holland, Asad Bashey
T-replete haploidentical donor transplants using posttransplant cyclophosphamide (haplo) have greatly expanded donor availability and are increasingly utilized. Haplo were originally performed using truly nonmyeloablative conditioning and a bone marrow graft. We have also developed myeloablative conditioning and peripheral blood stem cell (PBSC) grafts for use with haplo. However, some patients may not tolerate myeloablative conditioning but may still benefit from a more dose-intensified preparative regimen to control malignancy and diminish graft rejection...
2021: Advances in Hematology
https://read.qxmd.com/read/33790971/feasibility-study-of-the-hemotypesc-test-for-the-rapid-screening-of-sickle-cell-disease-in-c%C3%A3-te-d-ivoire
#33
JOURNAL ARTICLE
Jeannette Bassimbié Kakou Danho, Yao Nicaise Atiméré, Daouda Koné, Donafologo Daouda Yéo, Line Couitchéré
Sickle cell disease is a hereditary disease that predominantly affects black people. It is very widespread in sub-Saharan Africa, particularly at the Lehmann "sickle belt" level, where the prevalence of the hemoglobin S involves at least 10% of the population in West Africa and can reach 40% in Central Africa. In Côte d'Ivoire, the prevalence of the hemoglobin S is about 12-14% in the general population and about 11.71% in the child population in Abidjan. On the other hand, its coexistence with other hemoglobin phenotypes such as AC (6...
2021: Advances in Hematology
https://read.qxmd.com/read/33747086/safe-blood-transfusion-practices-among-nurses-in-a-major-referral-center-in-ghana
#34
JOURNAL ARTICLE
Agnes Asare Bediako, Rasheed Ofosu-Poku, Andrews Adjei Druye
Errors in transfusion of blood and blood products can lead to preventable morbidity and mortality. Nurses constitute a significant aspect of the transfusion process as they are the last in the chain of getting blood directly to the patient. They must, therefore, be conversant with the current standard of national and international guidelines on blood transfusion and appropriate management of adverse transfusion events. This study assesses the knowledge and practices of blood transfusion safety among nurses at Komfo Anokye Teaching Hospital...
2021: Advances in Hematology
https://read.qxmd.com/read/33628255/oral-factor-xa-inhibitors-versus-warfarin-for-the-treatment-of-venous-thromboembolism-in-advanced-chronic-kidney-disease
#35
JOURNAL ARTICLE
Tania Ahuja, Kelly Sessa, Cristian Merchan, John Papadopoulos, David Green
INTRODUCTION: Warfarin remains the preferred oral anticoagulant for the treatment of venous thromboembolism (VTE) in patients with advanced chronic kidney disease (CKD). Although the direct oral anticoagulants (DOACs) have become preferred for treatment of VTE in the general population, patients with advanced CKD were excluded from the landmark trials. Postmarketing, safety data have demonstrated oral factor Xa inhibitors (OFXais) such as apixaban and rivaroxaban to be alternatives to warfarin for the prevention of stroke and systemic embolism in patients with atrial fibrillation...
2021: Advances in Hematology
https://read.qxmd.com/read/33628254/efficacy-and-tolerance-of-vascular-electrical-stimulation-therapy-in-the-management-of-vaso-occlusive-crises-in-patients-with-sickle-cell-disease-a-phase-ii-single-centre-randomized-study-in-ivory-coast
#36
JOURNAL ARTICLE
Renée-Paule Botti, Sie Saïda Bokoum, Etienne L'Hermite, Dohoma Alexis Silue, Boidy Kouakou, Sarah Anastasie Bognini, Serge Arnaud Agoua, Edgar Mandeng Ma Linwa, Roméo Ayemou, Kouassi Gustave Koffi
BACKGROUND: Vaso-occlusive crisis (VOC) is the primary cause of hospitalization in patients with sickle cell disease. Treatment mainly consists of intravenous morphine or nonsteroidal anti-inflammatory drugs (NSAIDs), which have many dose-related side effects. The question arises as to whether vascular electrical stimulation therapy (VEST) could be effective or not on VOCs. OBJECTIVE: To measure the effectiveness and safety of VEST in reducing the median time spent in severe VOC...
2021: Advances in Hematology
https://read.qxmd.com/read/33531904/obesity-as-a-possible-risk-factor-for-progression-from-monoclonal-gammopathy-of-undetermined-significance-progression-into-multiple-myeloma-could-myeloma-be-prevented-with-metformin-treatment
#37
REVIEW
Ademar Dantas da Cunha Júnior, Dalila Luciola Zanette, Fernando Vieira Pericole, Sara Teresinha Olalla Saad, José Barreto Campello Carvalheira
Obesity is increasingly associated with the transformation of monoclonal gammopathy of undetermined significance (MGUS) into multiple myeloma ( MM). Obesity, MGUS, and MM share common etiopathogenesis mechanisms including altered insulin axis and the action of inflammatory cytokines. Consistent with this interconnection, metformin could predominantly exert inhibition of these pathophysiological factors and thus be an attractive therapeutic option for MGUS. Despite the possible clinical significance, only a limited number of epidemiological studies have focused on obesity as a risk factor for MGUS and MM...
2021: Advances in Hematology
https://read.qxmd.com/read/33299420/enhanced-hypercoagulability-in-sickle-cell-anaemia-patients-with-chronic-leg-ulcers
#38
JOURNAL ARTICLE
David Sackey, Yvonne Dei-Adomakoh, Edeghonghon Olayemi
Sickle Cell Anaemia (SCA) is associated with a hypercoagulable state resulting in a predisposition to venous thromboembolism. With improvements in the quality of care, more patients with SCA survive into adulthood with an associated increase in the frequency of end-organ damage and chronic complications such as chronic leg ulcers (CLUs). These ulcers rarely occur in the first decade of life and are recurrent, painful, and slow-to-heal. This study tested the hypothesis that coagulation is enhanced in SCA patients with CLU...
2020: Advances in Hematology
https://read.qxmd.com/read/33061980/magnitude-of-anemia-and-associated-factors-among-hiv-infected-children-receiving-antiretroviral-therapy-in-pastoral-community-ethiopia-a-retrospective-cross-sectional-study
#39
JOURNAL ARTICLE
Getahun Fentaw Mulaw, Fatima Ahmed Yesuf, Haftom Temesgen Abebe
Background: The two major comrbidities (anemia and poor nutrition) are common manifestations of HIV-infected children, which threaten their lives. In Ethiopia, there is limited information on the magnitude and factors associated with anemia among HIV-infected children. Thus, this study was aimed to determine the magnitude and factors associated with anemia among HIV-infected children receiving antiretroviral therapy in the Afar region, Ethiopia. Methods: A cross-sectional retrospective record review was conducted on a sample size of 102 HIV-infected children aged 6 months to < 15 years in selected ART sites of the Afar region from May 1 to 25, 2018...
2020: Advances in Hematology
https://read.qxmd.com/read/32963537/assessing-the-performance-of-extended-half-life-coagulation-factor-viii-fc-fusion-protein-by-using-chromogenic-and-one-stage-assays-in-saudi-hemophilia-a-patients
#40
JOURNAL ARTICLE
Tarek M Owaidah, Hazzaa A Alzahrani, Nouf S Al-Numair, Abdulmjeed O Alnosair, Amelita M Aguilos, Mahasen Saleh
BACKGROUND: The one-stage assay is the most common method to measure factor VIII activity (FVIII : C) in hemophilia A patients. The chromogenic assay is another two-stage test involving purified coagulation factors followed by factor Xa-specific chromogenic substrate. AIM: This study aimed to assess the discrepancy and correlation between the chromogenic and one-stage assays in measuring FVIII : C levels in hemophilia patients receiving Extended Half-Life Elocta® as a recombinant extended half-life coagulation factor...
2020: Advances in Hematology
journal
journal
42335
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.